Annual Operating Expenses
$8.76 M
+$4.75 M+118.28%
December 1, 2023
Summary
- As of February 7, 2025, BIAF annual total operating expenses is $8.76 million, with the most recent change of +$4.75 million (+118.28%) on December 1, 2023.
- During the last 3 years, BIAF annual operating expenses has risen by +$6.16 million (+236.54%).
- BIAF annual operating expenses is now at all-time high.
Performance
BIAF Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.88 M
-$193.60 K-6.29%
September 1, 2024
Summary
- As of February 7, 2025, BIAF quarterly total operating expenses is $2.88 million, with the most recent change of -$193.60 thousand (-6.29%) on September 1, 2024.
- Over the past year, BIAF quarterly operating expenses has increased by +$105.90 thousand (+3.81%).
- BIAF quarterly operating expenses is now -6.29% below its all-time high of $3.08 million, reached on June 1, 2024.
Performance
BIAF Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BIAF Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +118.3% | +3.8% |
| 3 y3 years | +236.5% | +3.8% |
| 5 y5 years | +236.5% | +3.8% |
BIAF Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +297.2% | -6.3% | +337.1% |
| 5 y | 5-year | at high | +297.2% | -6.3% | +487.1% |
| alltime | all time | at high | +297.2% | -6.3% | +487.1% |
BioAffinity Technologies Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.88 M(-6.3%) |
| Jun 2024 | - | $3.08 M(+10.8%) |
| Mar 2024 | - | $2.78 M(-3.9%) |
| Dec 2023 | $8.76 M(+118.3%) | $2.89 M(+14.8%) |
| Sep 2023 | - | $2.52 M(+40.1%) |
| Jun 2023 | - | $1.80 M(+15.3%) |
| Mar 2023 | - | $1.56 M(-4.1%) |
| Dec 2022 | $4.02 M | $1.63 M(+66.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $977.20 K(+42.6%) |
| Jun 2022 | - | $685.30 K(-5.7%) |
| Mar 2022 | - | $727.00 K(+10.2%) |
| Dec 2021 | $2.21 M(-15.3%) | - |
| Dec 2021 | - | $659.80 K(+25.4%) |
| Sep 2021 | - | $526.30 K(-0.6%) |
| Jun 2021 | - | $529.60 K(+7.8%) |
| Mar 2021 | - | $491.20 K |
| Dec 2020 | $2.60 M | - |
FAQ
- What is bioAffinity Technologies annual total operating expenses?
- What is the all time high annual operating expenses for bioAffinity Technologies?
- What is bioAffinity Technologies annual operating expenses year-on-year change?
- What is bioAffinity Technologies quarterly total operating expenses?
- What is the all time high quarterly operating expenses for bioAffinity Technologies?
- What is bioAffinity Technologies quarterly operating expenses year-on-year change?
What is bioAffinity Technologies annual total operating expenses?
The current annual operating expenses of BIAF is $8.76 M
What is the all time high annual operating expenses for bioAffinity Technologies?
bioAffinity Technologies all-time high annual total operating expenses is $8.76 M
What is bioAffinity Technologies annual operating expenses year-on-year change?
Over the past year, BIAF annual total operating expenses has changed by +$4.75 M (+118.28%)
What is bioAffinity Technologies quarterly total operating expenses?
The current quarterly operating expenses of BIAF is $2.88 M
What is the all time high quarterly operating expenses for bioAffinity Technologies?
bioAffinity Technologies all-time high quarterly total operating expenses is $3.08 M
What is bioAffinity Technologies quarterly operating expenses year-on-year change?
Over the past year, BIAF quarterly total operating expenses has changed by +$105.90 K (+3.81%)